A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis ; volume:8 ; number:1 ; day:18 ; month:12 ; year:2018 ; pages:1-13 ; date:12.2018
Scientific reports ; 8, Heft 1 (18.12.2018), 1-13, 12.2018
- Urheber
-
Farzaneh Behelgardi, Maryam
Zahri, Saber
Mashayekhi, Farhad
Mansouri, Kamran
Asghari, S. Mohsen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-36394-0
- URN
-
urn:nbn:de:101:1-2019012821231949978028
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Farzaneh Behelgardi, Maryam
- Zahri, Saber
- Mashayekhi, Farhad
- Mansouri, Kamran
- Asghari, S. Mohsen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies
Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer
Untersuchungen zur transkriptionellen Regulation von vegf-A und vegf-D in humanen Magenkarzinomzellen
Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors
Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15
Dipeptidyl peptidase IV inhibition activates CREB and improves islet vascularization through the VEGF-A, VEGFR-2 pathway
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Glioma angiogenesis is boosted by ELK3 activating the HIF-1 $$\alpha$$ α /VEGF-A signaling axis
Correction: MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer
Oxidized LDL promotes EMS-induced angiogenesis by increasing VEGF-A expression and secretion by endometrial cells
ETHE1 dampens colorectal cancer angiogenesis by promoting TC45 Dephosphorylation of STAT3 to inhibit VEGF-A expression
Genetic variation determines VEGF-A plasma levels in cancer patients
Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies
Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer
Untersuchungen zur transkriptionellen Regulation von vegf-A und vegf-D in humanen Magenkarzinomzellen
Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors
Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15
Dipeptidyl peptidase IV inhibition activates CREB and improves islet vascularization through the VEGF-A, VEGFR-2 pathway
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Glioma angiogenesis is boosted by ELK3 activating the HIF-1 $$\alpha$$ α /VEGF-A signaling axis
Correction: MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer
Oxidized LDL promotes EMS-induced angiogenesis by increasing VEGF-A expression and secretion by endometrial cells
ETHE1 dampens colorectal cancer angiogenesis by promoting TC45 Dephosphorylation of STAT3 to inhibit VEGF-A expression
Genetic variation determines VEGF-A plasma levels in cancer patients
Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies
Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer
Untersuchungen zur transkriptionellen Regulation von vegf-A und vegf-D in humanen Magenkarzinomzellen
Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors
Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15
Dipeptidyl peptidase IV inhibition activates CREB and improves islet vascularization through the VEGF-A, VEGFR-2 pathway
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Glioma angiogenesis is boosted by ELK3 activating the HIF-1 $$\alpha$$ α /VEGF-A signaling axis
Correction: MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer
Oxidized LDL promotes EMS-induced angiogenesis by increasing VEGF-A expression and secretion by endometrial cells
ETHE1 dampens colorectal cancer angiogenesis by promoting TC45 Dephosphorylation of STAT3 to inhibit VEGF-A expression